121 related articles for article (PubMed ID: 8384115)
1. Antagonism of non-NMDA receptors inhibits handling-induced, strychnine-potentiated convulsions.
McAllister KH
Eur J Pharmacol; 1993 Feb; 231(2):309-12. PubMed ID: 8384115
[TBL] [Abstract][Full Text] [Related]
2. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
3. Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions.
Eblen F; Löschmann PA; Wüllner U; Turski L; Klockgether T
Eur J Pharmacol; 1996 Mar; 299(1-3):9-16. PubMed ID: 8901001
[TBL] [Abstract][Full Text] [Related]
4. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
Folbergrová J
Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
[TBL] [Abstract][Full Text] [Related]
5. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
6. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.
De Sarro G; Renne S; Nava F; De Sarro A
J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713
[TBL] [Abstract][Full Text] [Related]
7. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists.
Berg M; Bruhn T; Johansen FF; Diemer NH
Pharmacol Toxicol; 1993 Nov; 73(5):262-8. PubMed ID: 8115308
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in mice.
McAllister KH
Eur J Pharmacol; 1992 Jan; 211(1):105-8. PubMed ID: 1535594
[TBL] [Abstract][Full Text] [Related]
9. Glycine potentiates strychnine-induced convulsions: role of NMDA receptors.
Larson AA; Beitz AJ
J Neurosci; 1988 Oct; 8(10):3822-6. PubMed ID: 2903914
[TBL] [Abstract][Full Text] [Related]
10. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate antagonist activity of alpha- and beta-sulfallorphans.
Shukla VK; Lemaire S
J Pharmacol Exp Ther; 1997 Jan; 280(1):357-65. PubMed ID: 8996216
[TBL] [Abstract][Full Text] [Related]
12. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
[TBL] [Abstract][Full Text] [Related]
13. Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes.
Schoepp DD; Gamble AY; Salhoff CR; Johnson BG; Ornstein PL
Eur J Pharmacol; 1990 Jul; 182(3):421-7. PubMed ID: 2171944
[TBL] [Abstract][Full Text] [Related]
14. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
[TBL] [Abstract][Full Text] [Related]
15. Glutamate receptor antagonists block cocaine-induced convulsions and death.
Rockhold RW; Oden G; Ho IK; Andrew M; Farley JM
Brain Res Bull; 1991 Nov; 27(5):721-3. PubMed ID: 1684527
[TBL] [Abstract][Full Text] [Related]
16. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
17. Cobalt accumulation in neurons expressing ionotropic excitatory amino acid receptors in young rat spinal cord: morphology and distribution.
Nagy I; Woolf CJ; Dray A; Urbán L
J Comp Neurol; 1994 Jun; 344(3):321-35. PubMed ID: 8063957
[TBL] [Abstract][Full Text] [Related]
18. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
Chapman AG; al-Zubaidy Z; Meldrum BS
Eur J Pharmacol; 1993 Feb; 231(2):301-3. PubMed ID: 8453982
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties and H+ sensitivity of excitatory amino acid receptor channels in rat cerebellar granule neurones.
Traynelis SF; Cull-Candy SG
J Physiol; 1991 Feb; 433():727-63. PubMed ID: 1726797
[TBL] [Abstract][Full Text] [Related]
20. Are NMDA or AMPA/kainate receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury?
Prehn JH; Lippert K; Krieglstein J
Eur J Pharmacol; 1995 Jan; 292(2):179-89. PubMed ID: 7720791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
